| Item Type | Name |
|
Concept
|
Severity of Illness Index
|
|
Academic Article
|
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.
|
|
Academic Article
|
Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent.
|
|
Academic Article
|
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
|
|
Academic Article
|
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
|
|
Academic Article
|
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia.
|
|
Academic Article
|
Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
|
|
Academic Article
|
Reversal of emphysema by restoration of pulmonary endothelial cells.
|
|
Academic Article
|
The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
|
|
Academic Article
|
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
|
|
Academic Article
|
Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema.
|
|
Academic Article
|
Clinical significance of radiologic characterizations in COPD.
|
|
Academic Article
|
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease.
|
|
Academic Article
|
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.
|
|
Academic Article
|
Interstitial lung disease, lung cancer, lung transplantation, pulmonary vascular disorders, and sleep-disordered breathing in AJRCCM in 2004.
|
|
Academic Article
|
Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial.
|
|
Academic Article
|
The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model.
|
|
Academic Article
|
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
|
|
Academic Article
|
Acute exacerbation of chronic bronchitis: expanding short-course therapy.
|
|
Academic Article
|
Predicting pulmonary fibrosis disease course from past trends in pulmonary function.
|
|
Academic Article
|
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis.
|
|
Academic Article
|
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
|
|
Academic Article
|
Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease.
|
|
Academic Article
|
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
|
|
Academic Article
|
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
|
|
Academic Article
|
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting ?2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.
|
|
Academic Article
|
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
|
|
Academic Article
|
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
|
|
Academic Article
|
Association between Emphysema and Chronic Obstructive Pulmonary Disease Outcomes in the COPDGene and SPIROMICS Cohorts: A Post Hoc Analysis of Two Clinical Trials.
|
|
Academic Article
|
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline.
|
|
Academic Article
|
Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations.
|
|
Academic Article
|
Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS.
|
|
Academic Article
|
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
|
|
Academic Article
|
The role of pulmonary function testing in pulmonary fibrosis.
|
|
Academic Article
|
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials.
|
|
Academic Article
|
Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort.
|
|
Academic Article
|
Update in diffuse parenchymal lung diseases 2005.
|
|
Academic Article
|
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
|
|
Academic Article
|
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
|
|
Academic Article
|
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
|
|
Academic Article
|
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
|
|
Academic Article
|
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.
|
|
Academic Article
|
Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort.
|
|
Academic Article
|
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.
|
|
Academic Article
|
Effects of baseline symptom burden on treatment response in COPD.
|
|
Academic Article
|
Surgical therapy for chronic obstructive pulmonary disease.
|
|
Academic Article
|
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
|
|
Academic Article
|
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
|
|
Academic Article
|
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions.
|
|
Academic Article
|
CT metrics of airway disease and emphysema in severe COPD.
|
|
Academic Article
|
Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease.
|
|
Academic Article
|
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.
|
|
Academic Article
|
Longitudinal change in the BODE index predicts mortality in severe emphysema.
|
|
Academic Article
|
Prevalence and clinical correlates of bronchoreversibility in severe emphysema.
|
|
Academic Article
|
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS).
|
|
Academic Article
|
Relationship between diffusion capacity and small airway abnormality in COPDGene.
|
|
Academic Article
|
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
|
|
Academic Article
|
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease.
|
|
Academic Article
|
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
|
|
Academic Article
|
Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity.
|
|
Academic Article
|
Pharmacotherapy and Mortality in Chronic Obstructive Pulmonary Disease.
|
|
Academic Article
|
Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
|
|
Academic Article
|
Sex differences in severe pulmonary emphysema.
|
|
Academic Article
|
Spirometry utilization for COPD: how do we measure up?
|
|
Academic Article
|
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved?Spirometry in SPIROMICS.
|